Florida judge denies IV Harmony Clinic bid to dismiss of Novo Nordisk claims
MLex Summary: IV Harmony Clinic must face allegations it violated the Lanham Act and Florida law when it falsely advertised its compounded semaglutide as approved by the US Food and Drug Administration,...To view the full article, register now.
Already a subscriber? Click here to view full article